IP Library Granted Patent US 8,257,945
Granted Patent B2
US 8,257,945 · App. 10/489,136 · Granted Sep 4, 2012

Identification of eukaryotic internal ribosome entry site (IRES) elements

Assignee: Icon Genetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,257,945
App. No.
10/489,136
Granted
Sep 4, 2012
Kind
B2
Abstract

A method of search for and identification of a eukaryotic IRES element active in cap-independent translation of RNA in eukaryotic cells is provided, comprising the following steps: i) screening eukaryotic mRNA sequences or corresponding DNA sequences for a potential IRES element having a block of nucleotides having: a) a length of at least 30 nucleotides; b) an adenine nucleotide content of at least 40 mol-%; and c) a pyrimidine nucleotide content of less than 40 mol-%; ii) inserting said potential IRES element into a linear dicistronic construct between an upstream gene and a downstream GUS reporter gene, whereby said potential IRES element is positioned for IRES-dependent translation of said downstream GUS gene and whereby said upstream gene is preceded by a stable hairpin structure to prevent IRES-independent translation of said genes; and iii) testing said potential IRES element for IRES-dependent translation of said GUS gene in a rabbit reticulocyte lysate or in a wheat germ extract in vitro translation assay, whereby GUS gene expression is quantitated preferably relative to a construct having a reference IRES element or a non-IRES element between said upstream gene and said GUS gene.

Claims (8)

1. A process of expressing a nucleotide sequence of interest in eukaryotic cell(s), wherein the process comprises introducing into said cell(s) a vector comprising said nucleotide sequence of interest operably linked to an upstream IRES element of eukaryotic origin, wherein the IRES element comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:8, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:18, and SEQ ID NO:20, whereby said nucleotide sequence of interest is translated cap-independently by way of said IRES element.

2. The process of claim 1 , wherein said nucleotide sequence of interest is expressed as part of a bicistronic or a polycistronic mRNA.

3. The process of claim 1 , wherein the IRES element is of mammalian origin.

4. The process of claim 1 , wherein said eukaryotic cell is a plant cell.

5. The process of claim 1 , wherein said eukaryotic cell is an animal cell.

6. The process of claim 1 , wherein said eukaryotic cell is a yeast cell.

7. A process of expressing a nucleotide sequence of interest in eukaryotic cell(s), wherein the process comprises introducing into said cell(s) a vector comprising said nucleotide sequence of interest operably linked to an upstream IRES element of plant origin, wherein the IRES element comprises SEQ ID NO:20, whereby said nucleotide sequence of interest is translated cap-independently by way of said IRES element.

8. A process of expressing a nucleotide sequence of interest in eukaryotic cell(s), wherein the process comprises introducing into said cell(s) a vector comprising said nucleotide sequence of interest operably linked to an upstream IRES element, wherein the IRES element comprises SEQ ID NO:20, whereby said nucleotide sequence of interest is translated cap-independently by way of said IRES element.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2004
From: ATABEKOV, JOSEPH; DOROKHOV, YURII; SKULACHEV, MAXIM; IVANOV, PETER; GLEBA, YURI
To: ICON GENETICS, INC.
Reel/Frame 015115/0636 →
Continuity (1)
Related Publication 20050014150A1 · Jan 20, 2005